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Pluripotent stem cells (PSCs) hold great promise in
cell-based therapy, but the genomic instability seen
in culture hampers their full application. A greater
understanding of the factors that regulate genomic
stability in PSCs could help address this issue.
Here we describe the identification of Filia as a spe-
cific regulator of genomic stability in mouse embry-
onic stem cells (ESCs). Filia expression is induced
by genotoxic stress. Filia promotes centrosome
integrity and regulates the DNA damage response
(DDR) through multiple pathways, including DDR
signaling, cell-cycle checkpoints and damage repair,
ESC differentiation, and apoptosis. Filia depletion
causes ESC genomic instability, induces resistance
to apoptosis, and promotes malignant transfor-
mation. As part of its role in DDR, Filia interacts
with PARP1 and stimulates its enzymatic activity.
Filia also constitutively resides on centrosomes and
translocates to DNA damage sites andmitochondria,
consistent with its multifaceted roles in regulating
centrosome integrity, damage repair, and apoptosis.
INTRODUCTION
Pluripotent stem cells (PSCs) hold great potential for cell-based
regenerative medicine. However, genomic instability and tumor-
igenicity limit their full applications. Understanding the mecha-
nisms that regulate their genome stability is critical to address
this issue. These mechanistic insights are also important to
understand how pluripotent cells (e.g., germ cells and early em-
bryos) sustain their genome integrity to ensure the successful
development of an organism. Pluripotent cells are capable of
developing into all cell types, whereas somatic cells are cell
fate-restricted. Accordingly, pluripotent cells possess a higher
competence than somatic cells to protect their genetic integrity.684 Cell Stem Cell 16, 684–698, June 4, 2015 ª2015 Elsevier Inc.DNA damage response (DDR) is a fundamental and evolution-
arily conserved mechanism to preserve the genomic integrity of
cells (Behrens et al., 2014; Jackson and Bartek, 2009). Upon
DNA damage triggered by endogenous or exogenous insults,
cells elicit complicated and highly coordinated response net-
works, including damage sensing and signal transduction, which
trigger cell-cycle arrest and DNA repair. When the extent of
DNA damage is beyond repairable, cells undergo apoptosis
or senescence to prevent the passage of the mutations to
descendent cell populations. These responses are coordinated
at multiple levels of gene regulation, including at the transcrip-
tional, post-transcriptional, translational, and post-translational
levels. Recent advances have further extended our understand-
ing of the DDR by documenting cytoplasmic Golgi dispersal as a
novel component of the DDR network (Farber-Katz et al., 2014).
Because of the importance of DDR in genomic stability, its
dysfunction is closely associated with genetic diseases, tumori-
genicity, and tissue aging (Bartkova et al., 2005; Liang et al.,
2009; Rass et al., 2007). DDR has been studied intensively
in somatic cells, and many key players have been identified.
Compared with somatic cells, very few studies have been
conducted in pluripotent cells regarding their DDR network com-
ponents. Limited reports have suggested that PSCs employed
distinct strategies to cope with DNA damage (Wyles et al.,
2014). For instance, mouse embryonic stem cells (ESCs) bypass
the G1/S cell-cycle checkpoint because of an extremely short
G1 phase (van der Laan et al., 2013). Instead, intra-S and G2
cell-cycle checkpoints are critical for ESCs (Momcilovic et al.,
2011). PSCs predominantly employ error-free homolog recombi-
nation (HR) rather than the error-prone non-homologous end
joining (NHEJ) pathway to repair DNA double-strand break
(DSB) (Tichy et al., 2010). Moreover, PSCs utilize high mitochon-
drial priming and retention of constitutively active Bax at the
Golgi to sensitize them to DNA damage (Dumitru et al., 2012;
Liu et al., 2013). Although it is appreciated that DDR regulation
in PSCs is distinct from that in somatic cells, the key players
and their functional mechanisms remain unknown. In particular,
PSC-specific DDR factors have never been identified.
Filia (official name, KH domain containing 3; also known
as Ecat1) was first identified in mouse embryonic stem cells
(mESCs) (Mitsui et al., 2003). Its expression is restricted to
undifferentiated ESCs. Later studies reported its expression in
growing oocytes and identified two transcriptional isoforms.
The long isoform (1.6 kb) encodes a 70 kDa protein and is
predominantly expressed in ESCs, while the short isoform
(1.2 kb), encoding a 50 kDa protein, is primarily detected in
growing oocytes (Ohsugi et al., 2008). Functional analysis re-
vealed that Filia is not essential for ESC self-renewal (Mitsui
et al., 2003), whereas depletion of maternal Filia protein in
oocytes led to severe aneuploidy in cleavage stage embryos
(Zheng and Dean, 2009). Here we report Filia acts as a mESC-
specific regulator of DDR and safeguards genomic stability.
RESULTS
Loss of Filia Causes Genomic Instability and Promotes
Malignant Transformation of mESCs
To investigate the role of Filia in regulating genomic stability of
mESCs, we derived three Filia/ ESC lines—FK(I), FK(II), and
FK(III)—and two wild-type (WT) counterparts from Filia-targeted
mutant mice (Zheng and Dean, 2009). The success rates of ESC
derivation did not differ between mutant and WT blastocysts
(33.3%, [2 of 6] in WT versus 25% [3 of 12] in the Filia mutant),
indicating that Filia is not required for the derivation of ESCs.
Consistent with previous studies (Mitsui et al., 2003), loss of Filia
did not impair the self-renewal of ESCs. FK ESCs displayed a
comparable morphology, expression of pluripotency markers,
alkaline phosphatase staining, formation of embryonic bodies,
cell-cycle profiles, and growth competition ability compared
withWT cells (Figures S1A–S1C). No overt morphological abnor-
mality was observed in FK ESCs after 100 passages.
However, cytogenetic analysis of chromosome metaphase
spreads revealed that FK ESCs exhibited severe chromosome
abnormalities, including chromosome breaks (Figures 1A and
1B), fusion of chromosome ends (Figures 1A, 1C, and 1D), and
sister chromatid exchange (SCE) (Figure 1E). Consistently, FK
ESCs displayed a higher rate of chromosomal anaphase bridges
(Figures 1B and 1F) and an increase in DNA damage markers
such as gH2AX accumulation and focus formation (Figures 1G
and 1H). The increase in DNA damage in FK ESCs was further
validated by comet assay, a method that measures the extent
of DNA damage on a single-cell basis (Figure 1I). Moreover, FK
ESCs had high incidences of abnormal centrosomes, spindle
assembly (Figure 1J), and aneuploidy (Figures S1D and S1E).
These phenotypes were reproducibly observed in another
ESC line with a distinct genetic background in which Filia
expression was knocked down by an inducible short hairpin
RNA (shRNA) (Figures S2A–S2E), indicating they are not genetic
background-specific.
Genomic instability is known to promote cell transformation
and tumorigenesis. Accordingly, we assessed the tumorigenicity
of FK ESCs by injecting the unlabeled FK and GFP-labeled WT
ESCs into the right or left testis of the same non-obese diabetic
(NOD)/severe combined immunodeficiency (SCID) mouse.
Teratomas formed by FK ESCs (GFP) weighed more than those
formed by WT ESCs (GFP+) (Figures 1K–1M). Furthermore,
aggressive tumors lacking GFP expression were detected in
the pancreas (Figure 1N), suggesting that they were formed
by FK ESCs. Consistently, FK ESCs showed a delay in differen-tiation (Figure S1F). Therefore, we conclude that loss of Filia
causes genomic instability and promotes tumorigenesis.
Filia Is Induced by Genotoxic Insults and Is Required
for Activation of ATM and Chk2
Because FK ESCs displayed a severe DNA damage phenotype
under normal culture conditions, we sought to determine
whether Filia regulates DDR. Toward this goal, we investigated
whether Filia expression is regulated by genotoxic insults.
Indeed, the 70-kDa Filia was upregulated by DNA-damaging
agents such as UV light, etoposide, doxorubicin, camptothecin,
and hydroxyl urea (Nagy and Soutoglou, 2009; Figure 2A). The
50-kDa isoform was not detected in ESCs (Figure S3A). The
expression and upregulation of Filia was specific to ESCs;
mouse embryonic fibroblasts (MEFs) and mesenchymal stem
cells (MSCs) did not express Filia in either the untreated or
treated condition (Figure S3B).
We then systematically investigated the effects of Filia loss on
major DDR signaling components, including gH2AX, ATM, ATR,
Chk1, Chk2, and p53. Upon etoposide treatment, gH2AX,
p-ATM, p-ATR, p-Chk1, and p-Chk2 were induced and sus-
tained for at least 12 hr in WT ESCs (Figure 2B). In contrast,
gH2AX and p-ATM were initially induced at comparable levels
in FK and WT ESCs but failed to sustain in FK cells (Figure 2B;
Figure S3C). Strikingly, Chk2, one of the key substrates of
ATM, was not phosphorylated at all in FK ESCs (Figure 2B).
This suggests that Filia participates in the Chk2 activation via
mechanisms independent of ATM. Unlike the ATM-Chk2
signaling axis, ATR and Chk1 kinases were not significantly
affected by Filia loss (Figure 2B; Figure S3D). ATM/Chk2 regu-
lates p53 activity. Consistently, phosphorylation of p53 at
its S15 and S20 was impaired in FK ESCs compared with
WT ESCs (Figure 2B). To further define the domain necessary
for regulating the signal transduction, we stably expressed
full-length Filia, a Filia fragment containing amino acids (aas)
1–340, or hnRNP K homology (KH) domain (atypical RNA-
binding domain) containing aas 1–125, in FK ESCs (FK-Filia,
FK-340, and FK-KH rescue cells, respectively) (Figures S3A,
S3E, and S3F). The induction of gH2AX, p-ATM, p-Chk2, and
p-p53 were restored in FK-Filia and FK-340 (Figure 2B) but not
in FK-KH cells (Figure S3G). These data revealed that the
C terminus of Filia (aas 341–440) was dispensable for DDR
signaling. Moreover, these functions were independent of
the genetic background based on shRNA knockdown ESCs,
as described above (Figure S2A).
In somatic cells, ATM and Chk2 activation exhibited pulsatile
dynamics in response to DNA damage. Recurrent initiation of
ATM/Chk2 activation is an important mechanism to sustain
DDR (Batchelor et al., 2008). To better understand the dynamics
of ATM/Chk2 activation in ESCs and the influence of Filia loss on
ATM and Chk2 activation, we conducted a detailed time course
analysis. WT ESCs displayed two waves of ATM activation. Filia
loss did not affect the initial ATM activation between 1–4 hr post-
damage but completely abolished ATM activity thereafter (Fig-
ure 2C). This suggests that distinct mechanisms regulate two
phases of ATM activation, with the second phase relying on Filia.
Unlike ATM, Chk2 activation did not exhibit discrete phases in
ESCs. Moreover, Filia loss completely blocked Chk2 activation
(Figure 2C), implying that Filia is necessary for Chk2 activation.Cell Stem Cell 16, 684–698, June 4, 2015 ª2015 Elsevier Inc. 685
Figure 1. Filia Maintains Genomic Stability and Prevents Malignant Transformation of ESCs
(A) Metaphase chromosome spread of FK ESCs. Arrowheads indicate chromosome breaks (red) and chromosome end fusion (black).
(B) Frequencies of chromosome breaks and anaphase bridges in WT and FK ESCs. More than 200 cells were examined in each sample.
(C) Chromosome end fusion detected by T-FISH.
(D) Frequencies of metaphase with chromosome end fusion in WT and FK ESCs. More than 100metaphase spreads were examined in each sample. P, passage.
(E) SCE (arrowheads) in WT and FK ESCs. 50 cells were examined in each group.
(F) Anaphase bridges in FK ESCs.
(G) gH2AX foci in WT and FK ESCs.
(H) gH2AX accumulation in WT and FK cells detected by immunoblotting.
(I) Comet assay showing that FK ESCs had severe DNA damage.
(J) Centrosomes in FK and WT ESCs at P3 and P5. More than 200 cells were examined in each of the indicated groups.
(K) Teratomas formed from FK ESCs were bigger and weighed more than those from WT ESCs injected at different concentrations.
(L) Teratoma tissue formed by FK ESCs that were GFP-negative.
(M) Teratoma tissue formed by GFP-labeled WT ESCs.
(N) FK ESC formed tumors in the pancreas.
Data are represented as mean ± SEM. Scale bars, 10 mm. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figures S1 and S2.
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Figure 2. Filia Regulates DNA Damage Signaling
(A) Filia protein expression was upregulated by genotoxic insults.
(B) The induction of gH2AX, p-ATM, p-Chk2, and p-p53 was compromised in FK ESCs, whereas p-ATR or p-Chk1 was not affected. Re-expression of Filia or
Filia340 successfully rescued the defects.
(C) Detailed time course analysis of p-ATM, p-Chk2, and Filia expression in WT and FK ESCs treated with etoposide. Arrows indicate p-Chk2.
See also Figures S2 and S3.
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Figure 3. Filia Is Necessary for Cell Cycle
Checkpoints and DNA Damage Repair
(A) The S phase checkpoint was functional in WT
and FK-Filia rescue ESCs but failed in FK and FK-
340 cells. HU, hydroxyl urea.
(B) Similarly, FK ESCs lost the G2 checkpoint,
which was restored in FK-Filia but not FK-340
ESCs. Ctr, control. Etop, etoposide.
(C) WT, FK-Filia, and FK-340 ESCs could repair
DNA damage induced by etoposide treatment
whereas FK ESCs could not.
(D) DNA integrity assessment of WT, FK, FK-340,
and FK-Filia ESCs by comet assay showed
persistent DNA breaks in FK ESCs.
(E) Rad51 was recruited to DSB sites in WT, FK-
340, and FK-Filia ESCs upon DNA damage.
However, its recruitment was compromised in
FK ESCs. Squares indicate examples of gH2AX+
Rad51 foci. 50 cells were examined in each
sample.
Data are represented as mean ± SEM. Scale bars,
10 mm. ***p < 0.001. See also Figure S3.Of interest, Filia expression exhibited a similar oscillation pattern
as ATM activation in WT ESCs (Figure 2C). To further explore
the relationships among Filia, ATM, and Chk2, we inhibited
ATM kinase activity using a specific ATM inhibitor, KU55933,
and examined Filia expression and Chk2 activation. Inhibition
of ATM activity did not affect Filia expression but impaired
Chk2 activation (Figure S3H). These data suggest that Filia
functions upstream of ATM in DDR.
Filia Regulates Cell Cycle Checkpoints and DNA
Damage Repair
Cell-cycle checkpoint and DNA repair rely on DDR signaling
(Branzei and Foiani, 2008). For instance, Chk1 is required for initi-
ation of the G2/M checkpoint in mESCs (Liu et al., 2000), and
Chk2 is required for the maintenance of G2/M arrest (Hirao688 Cell Stem Cell 16, 684–698, June 4, 2015 ª2015 Elsevier Inc.et al., 2000). ATM is critical for both
G2/M checkpoint and DNA repair in
ESCs (Momcilovic et al., 2009; Yama-
moto et al., 2012). Cell-cycle analysis re-
vealed that the S and G2/M checkpoints
were impaired in FK ESCs, which could
be rescued by Filia (Figures 3A and 3B).
Intriguingly, expression of Filia340 failed
to restore cell-cycle checkpoints despite
its ability to rescue DDR signaling (Fig-
ures 3A and 3B). Therefore, cell-cycle
checkpoint defects in FK ESCs were not
simply a consequence of DDR signaling
failure. Rather, Filia itself participated in
the regulation of cell-cycle checkpoints,
and this function required its C terminus
(aas 341–440).
ATM activation is essential for DNA
damage repair (Yamamoto et al., 2012).
To investigate whether Filia loss impairs
DNA damage repair, we performed a
comet assay to evaluate the repaircompetence in WT, FK, FK-Filia, and FK-340 rescue ESCs.
ESCs were treated with etoposide, and the extent of DNA dam-
age was evaluated after 0 hr, 6 hr and 12 hr of recovery. Notably,
WT, FK-Filia, and FK-340 cells displayed a similar competence in
DNAdamage repair, whereas FK cells exhibited an impairment in
damage repair (Figure 3C). Although Filia340 was less efficient
than Filia at 6 hr, this difference disappeared at 12 hr post-recov-
ery (Figure 3C). Consistently, FK-Filia and FK-340 ESCs showed
similarly mild DNA damage compared with WT cells (Figure 3D),
supporting the notion that re-introduction of Filia or Filia340 into
FK ESCs is sufficient to restore DNA damage repair. Rad51 is a
key protein involved in HR-mediated DSB repair. InWT aswell as
in FK-Filia and FK-340 rescue ESCs treated with etoposide,
most gH2AX foci were co-localized with the Rad51 foci when
examined 12 hr post-damage (Figure 3E). However, in FK
Figure 4. Filia Is Required for ESCs to Undergo Differentiation and Apoptosis in Response to DNA Damage
(A) FACS analysis showed that a higher proportion of WT and FK-Filia ESCs were at sub-G1 phase, indicative of cell death after etoposide treatment.
(B) WT and FK-Filia ESCs expressed more active caspase-3 than FK and FK-340 ESCs in response to etoposide treatment.
(legend continued on next page)
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ESCs, the number and size of Rad51 foci decreased, and there
were a significant number of gH2AX foci lacking co-localized
Rad51 (Figure 3E). Notably, the recruitment of active DNA-
PKcs to DNA damage sites, a marker of NHEJ-mediated DSB
repair (Davis et al., 2014), was not affected by Filia loss (Fig-
ure S3I). This suggests that Filia depletion preferentially impairs
HR-mediated DSB repair. Rad51 protein was expressed at
comparable levels in WT, FK, FK-340 or FK-Filia ESCs (Fig-
ure S3J), implying that Filia facilitates the efficient recruitment
of Rad51 to the damage sites. It is intriguing that Filia340-
rescued cells are capable of repairing DNA damage despite
the lack of cell-cycle checkpoints. This suggests that cell-cycle
arrest is not a prerequisite for DNA damage repair and that the
two processes are regulated independently.
Filia Regulates Differentiation and Apoptosis of ESCs
in Response to DNA Damage
Elimination of cells with irreparable DNA damage is the last and
most critical safeguarding event in DDR. Stem cells display
hypersensitivity to DNA damage (Dumitru et al., 2012; Liu
et al., 2013) and are primed to undergo rapid differentiation
and apoptosis to ensure genome stability (Inomata et al.,
2009; Lin et al., 2005). FK ESCs did not encounter culture crisis
despite accumulated spontaneous DNA damage, suggesting
that hypersensitivity to DNA damage is impaired in these cells.
To test this hypothesis, we treated the ESCs with etoposide
and investigated the dynamics of differentiation and apoptosis.
Sub-G1 apoptotic cell analysis revealed that FK ESCs were
more resistant to cell death than WT ESCs (Figure 4A). Consis-
tently, there was a decrease of cleaved caspase-3, a critical
executioner and marker of apoptosis, in FK compared with
WT ESCs (Figure 4B). This phenotype was rescued by Filia
but not Filia340 (Figures 4A and 4B). This result indicates that
the C terminus of Filia (aas 341–440) was necessary for this
function. ESC differentiation is triggered by transactivation of
p53 that binds to the enhancer region of Nanog to suppress
its expression (Li et al., 2012; Lin et al., 2005). Consistently,
Nanog, but not Oct4, displayed significant downregulation
12 hr after damage in WT and FK-Filia ESCs but not in FK or
FK-340 cells (Figure 4C).
To more comprehensively evaluate the functional outcome
of Filia loss on cell survival in response to DNA damage, we
performed a clonal competition assay in which same numbers
of two types of ESCs were mixed, exposed to DNA damage,
and co-cultured for 6 days. To distinguish the two mixed cell
types, one was labeled with GFP expression. Compared with
WT ESCs, FK cells showed a higher survival rate (Figure 4D).
Furthermore, WT, but not FK ESCs, displayed a flattened
morphology indicative of ESC differentiation (Figure 4D). Consis-
tently, expression of Filia, but not Filia340, in FK ESCs restored
their hypersensitivity to DNA damage (Figure 4D). Therefore,
Filia plays a critical role in ensuring ESCs’ hypersensitivity to
DNA damage, and this depends on its C terminus.(C) Nanog was downregulated in WT and FK-Filia but not in FK or FK-340 ESCs
(D) Clonal competition assay revealed that FK ESCs were less sensitive to DNA
sensitivity to DNA damage. Shown are representative images of mixtures of WT
differentiation. Data are represented as mean ± SEM. **p < 0.01, ***p < 0.001.
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Function in DNA Damage Repair
Our data suggest that Filia, akin to p53 in somatic cells, functions
in two opposite aspects of DDR in ESCs. It is required for
DNA repair, which enables cells to survive the damage. It is
also essential for damaged cells to undergo differentiation
and apoptosis. Phosphorylation often correlates with a change
in protein functions. There is evidence to suggest that the S349
residue on Filia is subjected to phosphorylation in response to
DNA damage (Pines et al., 2011). Therefore, we investigated
whether S349 was indeed phosphorylated and whether this
modificationplayeda role inmodulatingFilia’s functions.Accord-
ingly, wemutated S349 into alanine (S349A) that can no longer be
phosphorylated and stably expressed this mutant in FK ESCs
(FK-S349A) (Figure S4A). FiliaS349A protein rescued the
observed defects in DDR signaling (Figure S4B) and intra-S and
G2/M cell-cycle checkpoints in FK ESCs (Figures S4C and
S4D). However, it failed to restore DNA repair, as demonstrated
by the comet assay under normal and etoposide-treated condi-
tions (Figures 5A and 5B). Consistently, FiliaS349A failed to
rescue Rad51 recruitment to damage sites (Figure S4E). As a
result, FK-S349A ESCs were more sensitive to DNA damage
and prone to undergo apoptosis compared with WT ESCs (Fig-
ures 5C–5E). Consequently, these cells could not be maintained
in culture for more than 12 passages. To further validate the
phosphorylation of S349, we generated a polyclonal antibody
that specifically recognizes the phosphorylated Filia at S349
(p-Filia(S349)). Immunoblotting revealed a specific, 70-kDa
band that displayed increasing intensity in response toDNAdam-
age in WT but not FK-S349A ESCs (Figure 5F). Together, these
data indicate that the S349 residue of Filia is phosphorylated in
response to DNA damage and that this modification is essential
for Filia’s function in DNA damage repair. Moreover, S349 is
not a substrate of ATM; suppressing ATM kinase activity with
KU55933 does not affect S349 phosphorylation (Figure S3H).
To further explore the biological significance of S349 phos-
phorylation, we substituted serine with aspartic acid to mimic
its phosphorylation and stably expressed FiliaS349D in FK
ESCs (FK-S349D rescue cells; Figure S4A). FiliaS349D restored
DDR signaling (Figure S4B) and cell-cycle checkpoints (Figures
S4C and S4D) but failed to rescue the damage repair (Figures
5A and 5B; Figure S4E). Surprisingly, S349D severely impaired
Filia’s ability in regulating apoptosis, which correlates with a
hyper-toleration of FK-S349D cells to DNA damage compared
with either WT or FK ESCs (Figures 5D, 5G, and 5H). Together,
these data support the notion that S349 phosphorylation is
required for DNA repair, whereas the non-phosphorylation
status might be critical for Filia’s pro-apoptotic function.
Filia Dynamically Translocates to Different Sub-Cellular
Sites in Response to DNA Damage
We next examined Filia’s sub-cellular localization under normal
and DNA damage conditions. 3xFLAG-tagged Filia, Filia340,after DNA damage.
damage than WT ESCs. Re-expression of Filia, but not Filia340, restored their
(GFP+) and FK ESC clones. Note that WT ESC clones (white arrow) initiated
Figure 5. S349 Is Phosphorylated to Modulate Filia’s Role in DNA Damage Repair
(A) After etoposide treatment, WT ESCs were more efficient to repair DNA damage than FK, FK-S349A, and FK-S349D ESCs.
(B) Consistently, untreated FK, FK-S349A, and FK-S349D ESCs had severe DNA damage compared with WT ESCs.
(C) Higher proportion of FK-S349A ESCs were dead compared with WT and FK ESCs after etoposide treatment.
(D) Consistently, FK-S349A ESCs expressed more active caspase-3 than WT, FK, and FK-S349D ESCs.
(E) A clonal competition assay confirmed that FK-S349A ESCs had superior sensitivity to DNA damage than WT cells.
(F) Immunoblotting with antibody specifically recognizing phosphorylated S349 in Filia validated this phosphorylation modification. Note that the phosphorylation
level was upregulated by DNA damage.
(G) Sub-G1 analysis indicated that FK-S349D ESCs were more resistant to apoptosis.
(H) A clonal competition analysis further confirmed the higher tolerance of FK-S349D ESCs to DNA damage than FK ESCs.
Data are represented as mean ± SEM. ***p < 0.001. See also Figures S3 and S4.
Cell Stem Cell 16, 684–698, June 4, 2015 ª2015 Elsevier Inc. 691
Figure 6. Filia Constitutively Localizes on Centrosomes and DNA Damage Stimulates Its Translocation to Damage Sites or Mitochondria
(A) Constitutive localization of Filia, but not p-Filia(S349), on centrosomes labeled by pericentrin.
(B) Immunoprecipitation (IP) combined with immunoblotting (IB) confirmed the interaction of Filia or Filia340 with Numa.
(legend continued on next page)
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FiliaS349A, or FiliaS349Dwere stably expressed in FK ESCs. Im-
munostaining revealed that Filia is primarily located in cytoplasm
regardless of cell-cycle or genotoxic damage (Figure S5A). Cen-
trosomes are considered as command centers for cellular control
and are known to integrate cell-cycle regulation and DNA repair
(Doxsey et al., 2005; Lo¨ffler et al., 2006; Shimada and Komatsu,
2009). To examine whether Filia is localized on centrosomes,
we extracted free cytosolic Filia and co-stained FLAG-tagged
Filia with pericentrin and g-tubulin, two integral components of
pericentriolar material. Filia accumulated on centrosomes at
interphase and mitotic phase (Figure 6A; Figure S5B) under
normal conditions. DNA damage did not enhance the centroso-
mal accumulation of Filia (Figure S5B), suggesting that this local-
ization was constitutive. Centrosomal localization was also
observed for Filia340, FiliaS349A, and FiliaS349D (Figure S5C).
However, p-Filia(S349) did not localize to the centrosome (Fig-
ure 6A). Interestingly, Chk2 resides on centrosomes of mESCs
(Hong and Stambrook, 2004). p-ATM was also detected on cen-
trosomes of WT and rescue ESCs but not FK cells (Figure S5D).
These findings suggest that centrosome-localized Filia may play
a role in regulating ATM, Chk2, and cell-cycle checkpoints.
The constitutive centrosomal localization of Filia implied a role
in regulating centrosome integrity. Centrosomes in FK ESCs
were abnormal (Figure 1J). This could be a consequence of
DNA damage (Bourke et al., 2007; Lo¨ffler et al., 2013). To
exclude this possibility, we examined the centrosome integrity
of FK-Filia, FK-Filia340, FK-S349A, and FK-S349D rescue
ESCs. Notably, all examined ESCs displayed grossly normal
centrosomes and spindle assemblies (Figure S5E), despite the
fact that sustained DNA damage was observed in FK-S349A
and FK-S349D ESCs (Figure 5B). This observation excluded
the causal relationship of DNA damage and centrosome defects
observed in FK ESCs. Rather, it suggests that Filia itself plays
a direct role in maintaining centrosome integrity. Indeed, co-
immunoprecipitation combined with mass spectrometry identi-
fied Numa, a critical regulator of spindle pore integrity (Silk
et al., 2009; Zeng, 2000), as an interacting protein of Filia on
the centrosome (Figure 6B). The C terminus of Filia (aas 341–
440) contributes to this interaction because there was an impair-
ment of interaction between Numa and Filia340 compared with
full-length Filia (Figure 6B).
In addition to the cytoplasmic distribution, there was a small
amount of Filia in nuclei, as determined by immunostaining and
nucleus fractionation (Figure S5A; Figure 6C). To confirm the
presence of nuclear Filia, we treated the WT and FLAG-Filia
rescue ESCs with leptomycin B (LPB) to inhibit nuclear protein
export (Alpatov et al., 2014; Tamanini et al., 1999). Nuclear local-(C) Nucleus fractionation documented the presence of Filia in the cytoplasm (C) a
p-Filia(S349) were exclusively detected in the cytoplasm and nucleus, respective
Filia and p-Filia. Whole lysates of FK-S349A ESCs were used as a control. Ctr, c
(D) Immunostaining revealed the nuclear localization of Filia but not FiliaS349A pr
sites labeled with gH2AX.
(E) In WT ESCs, p-Filia(S349) was detected in the nucleus under normal and D
p-Filia(S349) on DNA damage sites. FK-S349A cells served as a negative contro
(F) Mitochondria fractionation revealed the localization of Filia and FiliaS349A
treatment evoked their accumulation onmitochondria. However, little Filia340 or F
conditions. C represents the fraction of whole-cell lysates depleted of mitochond
(G) Immunostaining confirmed the localization of Filia but not p-Filia(S349) on mi
Scale bars, 10 mm. See also Figures S5 and S6.ization of Filia was clearly visible after LPB treatment (Figure 6D).
Under normal conditions, Filia was diffused in the nucleus. DNA
damage evoked an increase in both the abundance of nuclear
Filia and its translocation to the damage sites, as labeled by
gH2AX (Figures 6C and 6D). Intriguingly, S-to-A mutation
(FLAG-S349A cells) prevented the entry of Filia into nuclei
regardless of DNA damage (Figures 6C and 6D), indicating that
Filia S349 phosphorylation is required for its nuclear localization.
Consistently, p-Filia(S349) was exclusively stained for nuclei of
WT ESCs under normal conditions and co-localized with
gH2AX upon DNA damage (Figures 6C and 6E). Filia340 showed
a similar nuclear distribution as full Filia (Figures S6A and S6B),
which correlates with its ability to restore DNA repair. Intrigu-
ingly, FiliaS349D protein exhibited proper nuclear localization
(Figures S6A and S6B) despite its inability to repair DNA damage.
We next determined whether Filia translocated to mitochon-
dria upon apoptosis induction. Under normal conditions, a
basal level of Filia was detected in mitochondria, as assayed
by immunostaining and mitochondrial fractionation. Apoptosis
induction with etoposide triggered a robust translocation of Filia
into mitochondria (Figures 6F and 6G). Filia localization to
mitochondria was compromised in Filia340 and FiliaS349D,
whereas it was enhanced in FiliaS349A (Figure 6F; Figure S6C).
These results support the notion that localization of Filia in
mitochondria is necessary for its apoptosis-promoting role.
They also implied that mitochondrial translocation of Filia
requires its C terminus and S349 at the non-phosphorylated
status. Consistently, p-Filia(S349) was not detected inmitochon-
dria (Figure 6G).
Filia Interacts with PARP1 and Stimulates Its Enzymatic
Activity in DDR
To further explore the mechanistic basis by which Filia regu-
lates DDR, we performed co-immunoprecipitation combined
with mass spectrometry analysis. We identified PARP1 as
one of Filia’s interaction proteins (Figure 7A). PARP1 catalyzes
the poly(ADP-ribosyl)ation (PARylation) of its target proteins
and plays a key role in early DDR (De Vos et al., 2012; Krishna-
kumar and Kraus, 2010). The interaction between PARP1 and
Filia was validated in NIH/3T3 cells ectopically expressing Filia
(Figure 7B). The interaction between PARP1 and Filia is regu-
lated, and it was enhanced by DNA damage (Figure 7A). More-
over, the interaction did not require the C terminus of Filia
because Filia340 pulled down PARP1 efficiently (Figure 7A).
Although these two proteins interact, there was no obvious
co-localization between them. PARP1 was predominantly
distributed in nuclei (Figure S7A), whereas the majority of Filiand nucleus (N) of WT and FLAG-Filia rescued ESCs. However, FiliaS349A and
ly. LPB as well as etoposide treatment increased the nuclear accumulation of
ontrol. Etop, etoposide.
oteins. Etoposide treatment stimulated the recruitment of Filia to DNA damage
NA damage conditions. Etoposide treatment increased the accumulation of
l.
on mitochondria (M) marked by MTCO2. Apoptosis induction by etoposide
iliaS349D protein was detected onmitochondria under normal or DNA damage
ria.
tochondria marked with VDAC1.
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Figure 7. Filia Interacts with PARP1 and Stimulates Its Enzymatic Activity Which Amplify Filia’s Roles in DDR
(A) Immunoprecipitation combined with immunoblotting confirmed the interaction of Filia or Filia340 with PARP1 in ESCs under normal or DNA damage
conditions.
(B) Filia interacts with PARP1 in NIH/3T3 cells ectopically expressing Filia under normal or DNA damage conditions.
(C) FK ESCs had a much lower PAR level than WT ESCs. However, re-expression of Filia or its variants restored the PAR level.
(D) Similarly, ectopic expression of Filia or its variants in NIH/3T3 cells significantly increased the PAR level in response to DNA damage.
(E) Inhibition of PARP1 activity by AG14361 significantly attenuated ATM and Chk2 activation. Consequently, cells with deficient PARP1 activity were prone to
undergo apoptosis.
(legend continued on next page)
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was detected in the cytoplasm (Figure S5A). Unlike Filia (Fig-
ure 6D), PARP1 nuclear foci were typically not co-localized
with gH2AX foci induced by DNA damage (Figure S7A). These
observations support the notion that the interaction between
Filia and PARP1 is transient.
To determine whether PARP1 is responsible for PARylation
in ESCs, we inhibited PARP1 enzymatic activity using a specific
inhibitor, AG14361 (Calabrese et al., 2004; Figure S7B). Time
course analysis revealed that inhibition of PARP1 completely
abolished PARylation (Figure S7C), indicating that PARP1 plays
a major role in regulating PARylation in ESCs. We next examined
whether Filia regulates PARP1 activity by comparing PAR levels
between WT and FK ESCs. In WT ESCs, PAR levels increased
after etoposide treatment, whereas significantly less PAR was
detected in untreated or etoposide-treated FK cells examined
at 4 and 8 hr (Figure 7C). Therefore, Filia is necessary for robust
PARP1 activation in response to DNA damage. Intriguingly,
PARP1-dependent but Filia-independent PAR was elevated at
12 hr in FK cells (Figure 7C; Figure S7C). The Filia-independent
PAR displayed abnormal accumulation at the nucleolus (Fig-
ure S7D), which is known as a storage site for PAR in DDR
(Mortusewicz et al., 2007). Re-expression of Filia, Filia340,
FiliaS349A, or FiliaS349D in FK ESCs efficiently restored
PARP1 activity and PAR levels (Figure 7C). Importantly, differen-
tiating ESCs and somatic cells have much less PAR compared
with undifferentiated ESCs (Figures S7E and S7F). Ectopic
expression of Filia and its variants in NIH/3T3 cells significantly
increased PAR levels (Figure 7D). The majority of PAR was
detected in nuclei of ESCs expressing Filia, Filia340, and
FiliaS349D, whereas PAR was predominantly accumulated in
the cytoplasm of FK-S349A rescue cells (Figure S7G). This is
consistent with the cytoplasmic distribution of FiliaS349A.
Notably, localization of Filia to DNA damage site did not rely on
PAR modification (Figure S7H).
To determine whether PARP1 plays a role in mediating Filia
function in DDR, we inhibited PARP1 activity using AG14361
and examined its effects on ATM and Chk2 activation, cell-cy-
cle checkpoints, DNA damage repair, and apoptosis. Inhibition
of PARP1 significantly attenuated, but did not completely
block, ATM and Chk2 activation (Figure 7E). Notably, PARP1
inhibition caused the same extent of defects in cell-cycle
checkpoints and DNA damage repair as Filia knockout (Fig-
ures 7F–7H). Consistently, ectopic expression of Filia in NIH/
3T3 cells not only increased PAR levels (Figure 7D) but also
enhanced DNA damage repair in these cells (Figure 7I). How-
ever, DNA damage-induced apoptosis was not impaired by
PARP1 inhibition (Figure 7E). This suggests that PARP1 activ-
ity is not necessary for apoptosis induction. Together, these
data support the notion that Filia interacts with PARP1 and ac-
tivates its enzymatic activity in response to DNA damage,
which contributes to the observed roles of Filia in regulating
DDR signaling, cell-cycle checkpoints, and DNA damage
repair.(F–H) Inhibition of PARP1 activity in ESCs abolished S phase (F) and G2/M (G) c
(I) Ectopic expression of Filia in NIH/3T3 cells significantly enhanced their DNA
WT ESCs, and FK ESCs were used as controls.
In (H) and (I), cells were recovered for 12 hr.
Data are represented as mean ± SEM. ***p < 0.001. See also Figure S7.DISCUSSION
Compared with somatic cells, PSCs have superior competence
and unique strategies to cope with DNA damage to maintain
genomic integrity. In addition to using common proteins found
in somatic cells with alternative strategies (Dumitru et al.,
2012), PSCs possess unique proteins to safeguard their
genome integrity (Zalzman et al., 2010). However, little is known
regarding the PSC-specific factors in regulating genomic stabil-
ity. Here we identify an ESC-specific protein, Filia, as a powerful
regulator of genomic stability. Through its coordinated cyto-
plasmic and nuclear functions, Filia regulates centrosome integ-
rity and DDR at multiple levels. These include DDR signal trans-
duction, cell-cycle checkpoints, DNA damage repair, and
apoptosis. Therefore, Filia depletion not only causes robust
genomic instability but also impedes the elimination of
damaged cells by ESC differentiation or apoptosis. This, in
turn, increases the risk of transformation and tumorigenesis in
ESCs. In somatic cells, p53 plays similar dual regulatory roles
in DDR (Green and Kroemer, 2009). However, these well estab-
lished roles of p53 are not evident in mESCs (Zhao and Xu,
2010). We hypothesize that PSCs utilize specific factors such
as Filia to safeguard their genome integrity. Of note, reprogram-
ming somatic cells into induced PSCs (iPSCs) is characterized
by large variation in Filia (Ecat1) expression (Aoi et al., 2008;
Kaji et al., 2009; Takahashi and Yamanaka, 2006). This suggests
that Filia expression is a potential molecular marker that corre-
lates with iPSC quality.
Filia carries out its multiple functions through different mecha-
nisms. On one hand, Filia is dynamically translocated to centro-
somes, DNA damage sites, and mitochondria to execute its
regulation on DDR independent of PARP1. On the other hand,
Filia physically interacts with PARP1 and stimulates PARP1’s
enzymatic activity to regulate DDR. PARP1 plays a key role in
regulating DDR and genomic integrity (Krishnakumar and Kraus,
2010; Luo and Kraus, 2012). For instance, PARP1- or PAR-defi-
cient cells are compromised in ATM activation, DNA damage
signaling, cell-cycle checkpoints, and DNA repair (Aguilar-Ques-
ada et al., 2007; Haince et al., 2007; Min et al., 2013). Knockout
mice for Parp1 or Parp2 are hypersensitive to DNA-damaging
agents and display increased genomic instability after genotoxic
stress (Hassa et al., 2006). More than 100 PARylation targets
were identified in DDR, including PARP1 itself, histones, CDK2,
kinases, and damage repair proteins (Jungmichel et al., 2013).
Filia is uniquely expressed in ESCs, which correlates with high
PAR levels and a superior ability to maintain genomic stability
in these cells. Therefore, these findings support a model in which
activation of PARP1 by Filia contributes to the observed pheno-
types in ATM and Chk2 activation, cell-cycle checkpoints, and
DNA damage repair in FK ESCs.
Filia and PARP1 do not apparently co-localize. In addition,
FiliaS349A is able to stimulate PARP1 activity despite its
restrictive cytoplasmic distribution. These findings suggestell-cycle checkpoints and compromised DNA damage repair (H).
damage repair ability. NIH/3T3 cells, NIH/3T3 cells transfected with vectors,
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that the dynamic interaction between PARP1 and Filia and
activation of PARP1 by Filia occur in both the cytoplasm
and nuclei. PAR regulates the protein’s sub-cellular redistri-
bution, and this provides a possible explanation for the pres-
ence of PAR and p-ATM in the nuclei of FiliaS349A-rescued
ESCs.
Compared with Filia knockout, PARP1 inhibition caused a less
obvious defect in ATM and Chk2 activation in response to DNA
damage. Filia340 failed to rescue the defects in cell-cycle check-
points despite its ability to activate PARP1. These findings sug-
gest that Filia also regulates ATM-Chk2 activation and cell-cycle
checkpoints in a PARP1-independent manner. ATM activation
exhibits two phases, and the first phase is not overtly affected
by Filia knockout. This might be due to the presence of basal
levels of PAR in Filia knockout cells, which accounts for the first
phase of ATM activation. Centrosomes are known to integrate
many regulatory factors that control cell-cycle progression and
DDR. Cell-cycle regulators such as the Cdk-cyclin complex
(Bailly et al., 1992; Hinchcliffe et al., 1999), Chk1 (Kra¨mer et al.,
2004; Zhang et al., 2007), and Chk2 (Golan et al., 2010; Hong
and Stambrook, 2004; Zhang et al., 2007) are present on
centrosomes. Furthermore, DDR regulators such as ATM, ATR,
and DNA-PK have also been shown to reside on centrosomes
(Zhang et al., 2007). Consistently, we observed the localization
of p-ATM on centrosomes of ESCs. However, p-ATM was ab-
sent from centrosomes when Filia was depleted. Re-expression
of Filia340, FiliaS349A, or FiliaS349D, all of which localize on
centrosomes, restored a second wave of ATM activation.
Therefore, the centrosomally localized Filia may coordinate
the control of DDR signaling, cell-cycle checkpoints, and centro-
some integrity.
FiliaS349A- or FiliaS349D-rescued ESCs fail to repair DNA
damage despite the PARP1 activity and PAR levels being
normal. This is consistent with the idea that Filia also regulates
DNA damage repair in a PARP1-independent manner. The phos-
phorylation of S349 at the C terminus is necessary for Filia’s
nuclear localization. However, without the C terminus, Filia340
is localized to nuclei (Figure S6B). Notably, bioinformatics
analysis indicates that Filia340 (aas 1–340) contains a potential
nuclear localization signal (NLS). Therefore, it is possible that
the phosphorylation of S349 regulates NLS function. Specif-
ically, non-phosphorylated S349 suppresses NLS function,
whereas phosphorylation of S349 or simply removing the
C terminus activates NLS function. Upon LPB treatment, nuclear
Filia is diffusive in the absence of DNA damage. DNA damage
triggers the translocation of Filia to DNA damage sites, indicating
that Filia’s entry into nuclei and its translocation to DNA damage
sites are regulated separately. PARylation plays a critical role in
recruiting DNA repair proteins to damage sites (Krishnakumar
and Kraus, 2010; Tallis et al., 2014). However, localization of
Filia into DNA damage sites is regulated neither by PARylation
nor by interaction with PARP1.
In summary, our data demonstrate that Filia functions as the
first of its kind ESC-specific regulator of genome integrity. These
data support the notion that ESCs employ distinct mechanisms
and utilize specific factors, such as Filia, to safeguard their
genomic integrity. They also suggest that the Filia expression
level is a potential biomarker for the quality of iPSCs with regard
to genomic stability and transformation potential.696 Cell Stem Cell 16, 684–698, June 4, 2015 ª2015 Elsevier Inc.EXPERIMENTAL PROCEDURES
Derivation and Culture of Mouse ESCs
All experimental procedures and animal care were performed according to the
protocols approved by the Ethics Committee of the Kunming Institute of
Zoology, Chinese Academy of Sciences. MEF preparation, ESC derivation,
and culture were performed in standard ways (Evans and Kaufman, 1981).
ESC genotyping was performed as described previously (Zheng and Dean,
2009).
Cytogenetic Analysis and T-FISH
Metaphase chromosome spreads were prepared and stained with Giemsa
solution or DAPI. For telomere fluorescent in situ hybridization (T-FISH),
metaphase spreads were prepared. DNA was denatured and hybridized with
peptide-nucleic acid (PNA) telomere probes (Tel G-Alexa 488, PANAGENE,
F1010-5) (Lansdorp et al., 1996). DNA was counterstained with 40,6-diami-
dino-2-phenylindole, dihydrochloride (DAPI).
Immunoblotting and Immunofluorescent Staining
Immunoblotting and immunofluorescent staining were performed according to
standard procedures (Na¨rva¨ et al., 2012). The primary antibodies are listed in
Table S1. Rabbit polyclonal antibodies against Filia and p-Filia(S349) were
generated by Abmart.
Cell-Cycle Checkpoint Analysis
ESCs were treated with hydroxyl urea to induce replication stress, and
S-phase arrest was evaluated by 5-ethynyl-2’-deoxyuridine (EdU) pulse-chase
incorporation assay (Buck et al., 2008). The G2/M checkpoint was examined
by standard methods after treating ESCs with etoposide (Greer Card et al.,
2010).
Alkaline Comet Assay and Clonal Competition Assay
An alkaline comet assay was performed according to the standard procedure
(Tice et al., 2000). Comets were analyzed using CASP comet assay analysis
software (Andor Technology), and 100 cells were calculated in each sample.
The same numbers of two types of ESCs, of which one was labeled with
GFP expression, were mixed. The mixed ESCs were subjected to the same
genotoxic stress and co-culture. Colony growth was monitored daily, and
200 clones were examined at each time point.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
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